Destiny Hance
Vice President Equity Research
Ladenburg Thalmann
Destiny Hance currently serves as Associate Director of Research at Ladenburg Thalmann & Co. Inc., an Osaic Advantage Company. In this role, she leads a team responsible for building multi-functional financial models and publishing detailed research reports covering a range of public companies, primarily within the healthcare sector. Her work includes initiating coverage on emerging growth companies, producing event-driven updates, and conducting diligence through management calls, investor presentations, and participation in key scientific and industry conferences spanning orthopedics, spine, energy delivery, imaging, robotics, and cardiology.
Topic
4:45pm - 5:25pm
June 18, 2025 June 18, 2025
The SPAC Advantage as an “Alternative IPO” Technique
- Faster to public market than traditional underwritten IPOs
- Ability to share forecasts with investors (with resulting potential for higher valuation)
- Satisfying public company governance standards, including board composition and reporting structures
- Reduced market volatility risks – SPAC mergers have a fixed valuation, offering more stability in unpredictable markets
- Flexibility in deal structures – custom deal terms such as earnouts and PIPE financing, to attract high-potential private companies into going public
- Lower barrier to IPO – SPACs help bypass a lengthy and costly traditional IPO process
- Attractive to institutional investors that may not typically invest in smaller, underserved market segments
- Less dependence on underwriting – how companies in overlooked sectors can bypass the challenges of securing traditional IPO underwriters
